Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 1.520
-0.050 (-3.18%)
May 21, 2026, 3:00 PM CST
Kangmei Pharmaceutical Revenue
Kangmei Pharmaceutical had revenue of 1.08B CNY in the quarter ending March 31, 2026, a decrease of -16.89%. This brings the company's revenue in the last twelve months to 5.03B, down -4.81% year-over-year. In the year 2025, Kangmei Pharmaceutical had annual revenue of 5.25B with 1.22% growth.
Revenue (ttm)
5.03B
Revenue Growth
-4.81%
P/S Ratio
4.18
Revenue / Employee
916.37K
Employees
4,233
Market Cap
21.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.25B | 63.08M | 1.22% |
| Dec 31, 2024 | 5.19B | 315.12M | 6.47% |
| Dec 31, 2023 | 4.87B | 693.87M | 16.60% |
| Dec 31, 2022 | 4.18B | 27.63M | 0.67% |
| Dec 31, 2021 | 4.15B | -1.26B | -23.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition